Abstract
Purpose
To investigate the effects of Akt/ARK5 pathways on the metastatic potential of human breast cancer cells.
Materials and methods
The human ARK5 gene was transfected into MDA-MB-231 cells. Effects of ARK5 on MDA-MB-231 cells were investigated in vitro. The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were determined using an orthotopic xenograft tumor model.
Results
ARK5 enhanced the invasive and metastatic potential of MDA-MB-231 cells under regulation by Akt. The enhancement was associated with increasing MMP-2, MMP-9, and MT1-MMP expression. The results were further demonstrated by RNA interference experiment. In an in vivo study, we also demonstrated that ARK5-transfected breast cancer cells grew faster and had more pulmonary metastases than its parental counterparts.
Conclusion
ARK5 led to a more invasive phenotype and metastatic potential in human breast cancer dependent on Akt.
Similar content being viewed by others
References
Cavdar Z, Canda AE, Terzi C, Sarioglu S, Fuzun M, Oktay G (2011) Role of gelatinases (Mmp-2 and Mmp-9), vascular endothelial growth factor (Vegf) and endostatin on clinicopathological behavior of rectal cancer. Colorectal Dis 13:154–160
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM (2007a) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9:R76
Chang XZ, Wang ZM, Yu JM, Tian FG, Jin W, Zhang Y, Yu J, Li LF, Liu XF, Li ZW, Shao ZM (2007b) Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis 24:25–38
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM (2008) Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 111:65–78
Chang XZ, Yu J, Zhang XH, Yin J, Wang T, Cao XC (2009) Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells. J Cancer Res Clin Oncol 135:581–590
Ekstrand AI, Jonsson M, Lindblom A, Borg A, Nilbert M (2010) Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer. Fam Cancer 9:125–129
Fisher JS, Ju JS, Oppelt PJ, Smith JL, Suzuki A, Esumi H (2005) Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase. Am J Physiol Endocrinol Metab 289:E986–E992
Kusakai G, Suzuki A, Ogura T, Kaminishi M, Esumi H (2004a) Strong association of ARK5 with tumor invasion and metastasis. J Exp Clin Cancer Res 23:263–268
Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, Esumi H (2004b) ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol 164:987–995
Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, He QY, Cheung AL (2009) Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3 K/AKT signaling pathway. Int J Cancer 125:2576–2585
Morito N, Yoh K, Fujioka Y, Nakano T, Shimohata H, Hashimoto Y, Yamada A, Maeda A, Matsuno F, Hata H et al (2006) Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res 66:812–819
Niesler CU, Myburgh KH, Moore F (2007) The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. Exp Physiol 92:207–217
Nteliopoulos G, Marley SB, Gordon MY (2009) Influence of PI-3K/Akt pathway on Wnt signalling in regulating myeloid progenitor cell proliferation. Evidence for a role of autocrine/paracrine Wnt regulation. Br J Haematol 146:637–651
Ohta T, Isobe M, Takahashi T, Saitoh-Sekiguchi M, Motoyama T, Kurachi H (2009) The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome. Anticancer Res 29:4639–4647
Simon PO Jr, McDunn JE, Kashiwagi H, Chang K, Goedegebuure PS, Hotchkiss RS, Hawkins WG (2009) Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma. Int J Cancer 125:942–951
Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Esumi H (2003a) ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation. Oncogene 22:6177–6182
Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H (2003b) Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem 278:48–53
Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A, Esumi H (2004a) Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene 23:7067–7075
Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H (2004b) ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 24:3526–3535
Suzuki A, Iida S, Kato-Uranishi M, Tajima E, Zhan F, Hanamura I, Huang Y, Ogura T, Takahashi S, Ueda R et al (2005) ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene 24:6936–6944
Yan W, Fu Y, Tian D, Liao J, Liu M, Wang B, Xia L, Zhu Q, Luo M (2009) PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem Biophys Res Commun 382:631–636
Acknowledgments
This research was supported in part by the Grant from Tianjin Health Administration Science Foundation (No. 2010KZ72) and Tianjin Medical University Cancer Institute and Hospital Science Foundation (No.07B05).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Xin-Zhong Chang, Jie Yu and Hai-Yin Liu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chang, XZ., Yu, J., Liu, HY. et al. ARK5 is associated with the invasive and metastatic potential of human breast cancer cells. J Cancer Res Clin Oncol 138, 247–254 (2012). https://doi.org/10.1007/s00432-011-1102-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-011-1102-1